Wellgistics Health Scraps $15M WellCare Acquisition, Reports Q1 Sequential Revenue Growth
WGRX has more than doubled off its 52-week low of $0.07 on elevated volume (2.5× avg).
Summary
Wellgistics Health reported its first quarter 2026 financials and provided a business update, most notably terminating the non-binding letter of intent to acquire WellCare Today, an acquisition previously announced on May 14th for approximately $15 million. This reversal significantly alters the company's strategic growth plans. The company reported sequential revenue growth for Q1 2026 ($0.929M vs Q4 2025's $0.486M) and projected Q2 2026 revenue of $1.775 million. However, this press release's financial highlights contrast sharply with the 10-Q filed concurrently, which reported a drastic 85.6% year-over-year revenue decline, a going concern warning, and multiple Nasdaq delisting threats. While the company announced new partnerships with Tollo Health and expanded discussions with Datavault AI, these positive developments are overshadowed by the termination of a material acquisition and the severe financial distress outlined in the official SEC filing. Traders must reconcile the company's optimistic business updates and sequential growth figures with the dire overall financial health and delisting risks.
At the time of this announcement, WGRX was trading at $0.17 on NASDAQ in the Technology sector, with a market capitalization of approximately $21.1M. The 52-week trading range was $0.07 to $3.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Access Newswire.